Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Aberdeen sees first-half profits slip, but transformation 'on track'

(Sharecast News) - Investment management firm Aberdeen reported a slight dip in first-half profits due to efforts to improve efficiency, but said it is delivering well against its strategies with the business transformation "on track". The company, which runs asset management, investment advisory and D2C investment platform Interactive Investor, reported an adjusted operating profit (AOP) of £125m for the six months to 30 June, down 2% over last year, with adjusted net operating revenues down 6% at £628m.

AOP increased 25% at Interactive Investor to £69m, with trading revenues up 36% at £45m, helped by record trading volumes in April.

AOP also rose 3% in the investment division to £35m, though net operating revenues were down 9% at £371m due to changes in the asset mix, including net outflows in equities.

However, AOP in the advisory division slumped 35% to £42m due to higher expenses and a 14% slump in net operating revenues to £102m.

Aberdeen's transformation programme achieved £137m of run-rate savings by the end of the half, with the company on track to deliver at least the £150m of targeted annualised cost savings by the end of the year. The majority of these savings will benefit its investments division as it repositions the business to focus on credit, specialist equities and real assets.

Despite the dip in the group adjusted profit figures, IFRS profit before tax surged to £271m from £187m the year before as a result of £155m gains from the change in fair value of Aberdeen's stake in Phoenix as well as reduced restructuring and corporate transaction expenses.

The interim dividend was held at 7.3p per share.

"In the first six months of 2025 we have made good progress against our strategic ambition to become the UK's leading Wealth & Investments group. Our financial performance reflects our transition to achieving our growth and efficiency targets," said chief executive Jason Windsor.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.